Search company, investor...

Chronicity

chronicityinc.com

Founded Year

2006

Stage

Unattributed VC - II | Dead

Total Raised

$16.1M

Last Raised

$4M

About Chronicity

Chronicity is a provider of integrative retail clinical services for chronic health conditions such as Fibromyalgia and Chronic Fatigue and Attention Deficit Hyperactivity Disorder (ADHD).

Headquarters Location

16415 Addison RD Suite 600 Suite 600

Addison, Texas, 752001,

United States

972-788-4001

Missing: Chronicity's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Chronicity's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Chronicity News

FDA Warns Supplement Maker Over Misleading Claims

Sep 23, 2011

The U.S. Food and Drug Administration (FDA) just issued a warning letter to Chronicity Inc . that it must correct a number of false claims on its “NutriElements” brand supplement labels, as well as misleading claims on its Web site. Chronicity sells services and products to consumers complaining of chronic fatigue, fibromyalgia, learning disabilities, and attention deficit disorder (ADD), said the Chicago Tribune. The warning letter, dated September 7, stated that NutriElements supplements were inappropriately marketed with “therapeutic” claims. This means, said the Tribune, that the products, which promise to “cure, mitigate, treat or prevent the disease” are, now, unapproved drugs and under the purview of the FDA. The FDA named eight products: “Anti-Viral,” “Artesmisinin,” “Leuko-Stim,” “Chol-Less,” “Selenium 200 mcg,” “GastroHealth,” and “Omega 3,” stating that “the unlawful disease treatment and prevention claims on your website were too numerous to list in this letter,” reported the Tribune. According to Chronicity Chief Executive Officer (CEO) Dr. Richard Vance, Chronicity is in the midst of a reorganization; the mandated changes will be made to its Web site as soon as possible. “(The FDA letter) came as a surprise to me,” said Vance, who stepped in to his CEO position this February, said the Tribune. Vance said he has responded to the agency and agrees with the changes. “We want to make sure the language on the Web site is appropriate,” he said. “(The claims) shouldn’t have been up,” Vance added, according to the Tribune. Chronicity has begun to implement some of the changes. For instance, said the Tribune, the Leuko-Stim claim that the product “improves the ability to fight infections and decreases cancer risk” now states that “(Leuko-Stim) supports the body’s defense system when under stress,” citing a letter Chronicity wrote to the FDA. While medications undergo safety and efficacy testing in order to receive approval by the FDA for release to market, dietary supplements do not, noted the Tribune. In the case of supplements, manufacturers must ensure safety, efficacy, and proper labeling. Also, as we’ve previously noted, supplements made from products available on the U.S. market prior to 1994 can be sold with no agency review, including a wide variety currently available. Sellers of products containing substances unavailable prior to 1994, need only advise the FDA and do not require approval to be sold. About two-thirds of all Americans take some sort of dietary supplement and earlier this year, the FDA announced it is seeking clarification on safety rules in effect for dietary supplements, and was issuing draft guidelines meant to assist with firms’ compliance with the 1994 regulation of “new dietary ingredients in tablets, powders, liquids, and other supplements,” and mandates makers file a safety notification with the agency prior to marketing any dietary ingredient that was not on the market in 1994. Since the law’s passage, the agency said it only received about 700 such notifications, but believes over 55,000 dietary supplement products are being sold and marketed today. We previously wrote that Consumer Reports discussed its concern with the 1994 Dietary Supplement Health and Education Act (DSHEA), which it said is industry friendly and does not enable the FDA to regulate supplements as prescription medications. Of note, the Federal Trade Commission (FCC) is the agency that regulates herbal supplement marketing, which includes a ban on claims of medical condition treatment. This entry was posted in Pharmaceuticals . Bookmark the permalink .

Chronicity Frequently Asked Questions (FAQ)

  • When was Chronicity founded?

    Chronicity was founded in 2006.

  • Where is Chronicity's headquarters?

    Chronicity's headquarters is located at 16415 Addison RD Suite 600, Addison.

  • What is Chronicity's latest funding round?

    Chronicity's latest funding round is Unattributed VC - II.

  • How much did Chronicity raise?

    Chronicity raised a total of $16.1M.

  • Who are the investors of Chronicity?

    Investors of Chronicity include Chrysalis Ventures, Reservoir Venture Partners and SSM Partners.

  • Who are Chronicity's competitors?

    Competitors of Chronicity include One Medical, Pentec Health, ArisGlobal, DataTrak International, Shearwater Health and 16 more.

Compare Chronicity to Competitors

TriMedx Logo
TriMedx

TriMedx is a provider of clinical engineering services. Created by healthcare for healthcare, TriMedx understands that patients are the number one priority. Headquartered in Indianapolis, TriMedx started as a hospital clinical engineering department focusing on reducing expenses, optimizing service and enhancing the patient experience through innovative medical equipment management programs. Today, TriMedx is recognized around the globe as a leader in healthcare technology management. The company was founded in 1998 and is based in Indianapolis, Indiana.

Apelon Logo
Apelon

Apelon's terminology solutions help healthcare vendors, biomedical researchers, provider organizations, and government agencies improve the quality, comparability, and accessibility of clinical information. nnThe company's Support Services provide commercial grade support for open source terminology software, both for Apelon-hosted environments and for in-house implementations. In broad terms the company's support services fall into two categories: subscription services to manage terminology updates and revisions, and telephone-based professional support for the installation, management, and use of terminology-related open source software

Pentec Health Logo
Pentec Health

Pentec Health delivers nutritional support to dialysis patients who are unable to maintain adequate nutrition levels and provides specialized pain and spasticity management services to patients with intrathecal pumps. In both areas, Pentec Health is a clinical leader that focuses on outcomes management while providing high levels of patient and provider satisfaction. Pentec Health also provides deep reimbursement expertise and experience working with all types of payors to help patients obtain coverage.In June 2012, Norwest Equity Partners acquired Pentec Health from Frazier Healthcare Ventures and DW Healthcare Partners. The valuation of Pentec Health was undisclosed. Other terms of the deal were not released.

Paradigm Logo
Paradigm

Paradigm provides acute and ongoing catastrophic and complex case management services for traumatic brain injuries, spinal cord injuries, amputations, burns, wounds, and chronic pain. The company is a provider of complex and catastrophic medical management in the workers' compensation industry.

Norton Audits Logo
Norton Audits

Norton Audits aims to provide clinical trial monitoring, auditing, and training.

N
NCI Cancer Hospital

NCI Cancer Hospital is a private oncology centre in Malaysia that combines treatment and clinical research. NCI aims to provide a range of services from diagnosis, laboratory analysis, surgery, chemotherapy and radiotherapy. It operates to GCP and has conducted clinical trials for a number of pharmaceutical companies including Roche, BMS and AstraZeneca.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.